The global cell culture market size is expected to reach USD 53.17 billion by 2033, registering a CAGR of 11.21% from 2025 to 2033, according to a new report by Grand View Research, Inc. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques. For instance, in February 2023, SK Bioscience announced that its first cell culture-based quadrivalent influenza vaccine, SKYCellflu, was officially licensed in South America by Instituto de Salud Publica de Chile (Institute of Public Health, ISP).
Furthermore, vaccine development requires several expression analyses, quality control, and safety testing procedures, which use cell-based assays. As a result, the usage of cell culture products for such applications has witnessed high demand in recent years. In addition, with an increase in the incidence of infectious diseases, a rise in focus on prevention of disease outbreaks, and high R&D investments in vaccine technologies, vaccine production is projected to gain traction and boost market growth.Moreover, cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells.
This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention.Furthermore, several companies are engaged in strategic initiatives, such as market expansion, which can be attributed to market growth. For instance, in March 2021, Thermo Fisher Scientific, Inc. announced its expansion plans by investing USD 600 million into capital investments through 2022. Its cell culture media and process liquid sites in Scotland, Florida, and New York increased the production capacity of Gibco cell culture media, process liquids, and supplements. Such developments are expected to propel the market growth over the forecast period.
Request a free sample copy or view report summary: Cell Culture Market Report
By product, the consumables segment accounted for the largest market share in 2024 and is expected to witness significant growth during the forecast period.
By application, the biopharmaceutical production application segment dominated the market in 2024 with a revenue share of 32.78%. The diagnostics segment is expected to grow at the fastest CAGR from 2025 to 2033.
North America cell culture market held the largest market share of 36.38% in 2024. The cell culture industry in the U.S. is experiencing rapid growth, driven by the expansion of the biopharmaceutical industry and the increasing adoption of cell-based technologies and cell culture-based products.
The cell culture market in Asia Pacific is projected to expand at the fastest CAGR of 14.11% over the forecast period.
Grand View Research has segmented the global cell culture market report on the basis of product, application, and region:
Cell Culture Product Outlook (Revenue, USD Million, 2021 - 2033)
Consumables
Sera
Fetal Bovine Serum
Other
Reagents
Albumin
Others
Media
Serum-free Media
CHO Media
HEK 293 Media
BHK Medium
Vero Medium
Other Serum-free Media
Classical Media
Stem Cell Culture Media
Chemically Defined Media
Specialty Media
Other Cell Culture Media
Instruments
Culture Systems
Incubators
Centrifuges
Cryostorage Equipment
Biosafety Equipment
Pipetting Instruments
Cell Culture Application Outlook (Revenue, USD Million, 2021 - 2033)
Biopharmaceutical Production
Monoclonal Antibodies
Vaccines Production
Other Therapeutic Proteins
Drug Development
Diagnostics
Tissue Culture & Engineering
Cell and Gene Therapy
Toxicity Testing
Other Applications
Cell Culture Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Cell Culture Market
Sartorius AG
Danaher
Merck KGaA
Thermo Fisher Scientific, Inc.
Corning Inc.
Avantor, Inc.
BD
Eppendorf SE
Bio-Techne
PromoCell GmbH
"The quality of research they have done for us has been excellent..."